Next |
home / stock / phvs / phvs message board
Subject | By | Source | When |
---|---|---|---|
short squeeze all day | MT101 | investorshub | 06/24/2023 10:44:57 AM |
Price trading | subslover | investorshub | 06/23/2023 3:53:06 PM |
$PHVS short squeeze all day | subslover | investorshub | 06/23/2023 1:01:38 PM |
$PHVS got some short data | Pt3 | investorshub | 06/20/2023 2:31:13 AM |
MomentumIts gaining | subslover | investorshub | 06/19/2023 6:15:49 PM |
Good read | subslover | investorshub | 06/16/2023 2:33:36 AM |
what do you make of this data? | winna | investorshub | 06/07/2023 1:13:22 AM |
$PHVS Good read | europtiger | investorshub | 06/06/2023 9:48:08 AM |
$PHVS MomentumIts trading last up | Invest-in-America | investorshub | 06/05/2023 11:40:01 PM |
$PHVS is it bear time? Or do we go bull? | MT101 | investorshub | 06/04/2023 5:39:53 AM |
bears and bulls | Invest-in-America | investorshub | 06/03/2023 12:40:54 PM |
Anyone hear anything lately? Want to see this one go | Invest-in-America | investorshub | 06/03/2023 5:54:56 AM |
news out | Invest-in-America | investorshub | 06/02/2023 1:36:57 PM |
MomentumIts gaining up | europtiger | investorshub | 06/01/2023 11:27:40 PM |
short squeeze all day | MT101 | investorshub | 06/01/2023 12:16:17 PM |
where is the squeeze? | subslover | investorshub | 05/30/2023 1:33:53 PM |
$PHVS The now up | subslover | investorshub | 05/28/2023 5:11:12 PM |
$PHVS Found an interesting article | Invest-in-America | investorshub | 05/27/2023 9:32:33 AM |
Excellent call on the $12,00's. I just confirmed | subslover | investorshub | 01/04/2023 4:40:18 AM |
Yeah looking great my average now ist even | europtiger | investorshub | 12/29/2022 3:41:30 PM |
News, Short Squeeze, Breakout and More Instantly...
Pharvaris N.V. Company Name:
PHVS Stock Symbol:
NASDAQ Market:
RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, is currently enrolling End-of-Phase 2 meeti...
RAPIDe-3, a global pivotal Phase 3 study of deucrictibant for the on-demand treatment of HAE attacks, is currently enrolling End-of-Phase 2 meeting scheduled to discuss development plan of deucrictibant for the prophylaxis of HAE attacks Strengthened executive committee with hiring of D...
ZUG, Switzerland, April 04, 2024 (GLOBE NEWSWIRE) -- Pharvaris (NASDAQ:PHVS), a late-stage biopharmaceutical company developing novel, oral brad...